Nice

News

NICE blocks wider use of Jardiance, Forxiga in heart failure

Eli Lilly and Boehringer Ingelheim's Jardiance and AstraZeneca's Forxiga have not been recommended for NHS use as a treatment for symptomatic chronic heart failure (CHF) w

News

NICE says yes to digital CBT for children with anxiety

UK cost-effectiveness agency NICE has said that guided, self-help digital cognitive behavioural therapy (CBT) apps can be used by the NHS for initial treatment of children

News

NICE recommends first CAR-T cell therapy on NHS in England

Gilead Sciences and Kite, a Gilead company, have announced that the National Institute for Health and Care Excellence (NICE) has recommended Yescarta (axicabtagene ciloleucel; axi-cel) for

Market Access

Innovative Medicines Fund and the opportunity for ICSs-indus...

In June 2022, NHS England (NHSE) and the National Institute for Health and Care Excellence (NICE) launched the Innovative Medicines Fund (IMF).

News

NICE backs Alnylam's Amvuttra for rare form of amyloidosis

Alnylam's gene-silencing drug Amvuttra has been recommended as a treatment for hereditary transthyretin-related (ATTR) amyloidosis by NICE, paving the way for the drug to be made available

News

Female doctor with the stethoscope holding heart

NICE says statins should be used more widely in NHS

Cholesterol-lowering statin drugs could be available to millions more patients in the UK, if new recommendations from health technology assessment (HTA) organisation NICE are implemented.

NICE blocks wider use of Jardiance, Forxiga in heart failure

NICE says yes to digital CBT for children with anxiety

NICE recommends first CAR-T cell therapy on NHS in England

Innovative Medicines Fund and the opportunity for ICSs-indus...

NICE backs Alnylam's Amvuttra for rare form of amyloidosis

NICE says statins should be used more widely in NHS

On AI and computational support of biochemistry, with Alan R...

The AI imperative: Establishing the standard for modern clin...

Nice

Editor's Picks